α,α'-双[3-(N,N-二乙基氨基甲酰基)哌啶基]-对二甲苯对人血小板结构生理学的影响。
The effect of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene on human blood platelet structural physiology.
作者信息
Lasslo A, White J G
出版信息
Biochim Biophys Acta. 1984 Oct 17;777(1):37-40. doi: 10.1016/0005-2736(84)90494-2.
PMID:6435673
Abstract
alpha, alpha'-Bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene enhances human blood platelet membrane integrity by exerting a stabilizing action at the level of the dense tubular system in surface membrane complexes known to sequester platelet calcium.
摘要
α,α'-双[3-(N,N-二乙基氨基甲酰基)哌啶基]-对二甲苯通过在已知可隔离血小板钙的表面膜复合物的致密管状系统水平发挥稳定作用，增强人血小板膜的完整性。
相似文献
1
The effect of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene on human blood platelet structural physiology.α,α'-双[3-(N,N-二乙基氨基甲酰基)哌啶基]-对二甲苯对人血小板结构生理学的影响。
Biochim Biophys Acta. 1984 Oct 17;777(1):37-40. doi: 10.1016/0005-2736(84)90494-2.
2
Cytosolic ionized calcium in human platelets: the influence of collagen and a novel antiplatelet agent.人血小板中的胞质游离钙：胶原蛋白和一种新型抗血小板药物的影响。
Biochem Biophys Res Commun. 1991 Jun 14;177(2):888-93. doi: 10.1016/0006-291x(91)91873-b.
3
In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide.新型抗血小板药物α,α'-双[3-(N,N-二乙基氨基甲酰基)哌啶基]-对二甲苯二氢溴化物的体外和体内活性
Res Commun Chem Pathol Pharmacol. 1992 Dec;78(3):279-88.
4
Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.抗血栓形成的尼哌替丁类化合物对血小板活化因子诱导的人血小板聚集的抑制作用
Prostaglandins Leukot Essent Fatty Acids. 1995 May;52(5):309-18. doi: 10.1016/0952-3278(95)90032-2.
5
Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.R,S-（内消旋）-α,α'-双[3-（N,N-二乙基氨基甲酰基）哌啶基]-对二甲苯在犬体内外及小鼠体内的抗血小板作用
Gen Pharmacol. 1997 Apr;28(4):617-21. doi: 10.1016/s0306-3623(96)00272-8.
6
Antithrombotic nipecotamide increases cyclic AMP levels and inhibits protein phosphorylation in human platelets.抗血栓形成的烟酰胺增加人血小板中的环磷酸腺苷水平并抑制蛋白质磷酸化。
Life Sci. 1995;57(10):983-8. doi: 10.1016/0024-3205(95)02033-f.
7
[Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].[二磷酸腺苷、胶原蛋白和肾上腺素诱导的人血小板亚群中的血小板聚集]
Quad Sclavo Diagn. 1987 Sep;23(3):331-40.
8
Enantioselective antiplatelet actions of nipecotamides.烟酰胺类化合物的对映选择性抗血小板作用。
Thromb Res. 1993 Feb 15;69(4):361-7. doi: 10.1016/0049-3848(93)90035-m.
9
Preliminary in vivo studies on the platelet aggregation inhibitory activity of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide in beagle dogs.α,α'-双[3-(N,N-二乙基氨基甲酰基)哌啶基]-对二甲苯二氢溴化物对比格犬血小板聚集抑制活性的初步体内研究。
J Pharm Sci. 1988 May;77(5):464-5. doi: 10.1002/jps.2600770523.
10
Inhibition of thrombus formation in vivo by novel antiplatelet agent.新型抗血小板药物对体内血栓形成的抑制作用
Arteriosclerosis. 1990 May-Jun;10(3):367-71. doi: 10.1161/01.atv.10.3.367.
Zotero 插件